4 results match your criteria: "Rwanda Biomedical Center - Kigali[Affiliation]"
Implementation of an HIV Case Based Surveillance Using Standards-Based Health Information Exchange in Rwanda.
Stud Health Technol Inform
January 2024
Rwanda Biomedical Center - Kigali, Rwanda.
As Rwanda approaches the UNAIDS Fast Track goals which recommend that 95% of HIV-infected individuals know their status, of whom 95% should receive treatment and 95% of those on treatment achieve viral suppression, the country currently relies on an inefficient paper, and disjointed electronic, systems for case-based surveillance (CBS). Rwanda has established an ecosystem of interoperable systems based on open standards to support HIV CBS. Data were successfully exchanged between an EMR, a client registry, laboratory information system and DHIS-2 Tracker, and subsequently, a complete analytic dataset was ingested into MS-Power Business Intelligence (MS-PowerBI) for analytics and visualization of the CBS data.
View Article and Find Full Text PDFSafety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda.
Hepatol Commun
April 2020
Partners In Health Rwinkwavu Rwanda.
Direct-acting antivirals for hepatitis C virus (HCV) are highly effective and well-tolerated. However, only a small percentage of HCV-infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to HCV services, particularly in resource-limited settings such as sub-Saharan Africa.
View Article and Find Full Text PDFTrends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
AIDS
January 2015
aRegional Alliance for Sustainable Development, Kigali, Rwanda bCUNY School of Public Health, New York cAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York dThe State University of New Jersey, New Brunswick, New Jersey, USA eRwanda Military Hospital, Kigali fMasaka District Hospital, Kigali gCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda hInstitute of HIV/AIDS and Disease Prevention and Control, Rwanda Biomedical Center Kigali, Rwanda iCUNY School of Public Health and Hunter College, New York, New York, USA.
Background: Initiation of antiretroviral therapy (ART) in the advanced stages of HIV infection remains a major challenge in sub-Saharan Africa. This study was conducted to better understand barriers and enablers to timely ART initiation in Rwanda where ART coverage is high and national ART eligibility guidelines first expanded in 2007-2008.
Methods: Using data on 6326 patients (≥15 years) at five Rwandan clinics, we assessed trends and correlates of CD4 cell count at ART initiation and the proportion initiating ART with advanced HIV disease (CD4 <200 cells/μl or WHO stage IV).